Jessen, Frank
Spottke, Annika
Boecker, Henning
Brosseron, Frederic
Buerger, Katharina
Catak, Cihan
Fliessbach, Klaus
Franke, Christiana
Fuentes, Manuel
Heneka, Michael T.
Janowitz, Daniel
Kilimann, Ingo
Laske, Christoph
Menne, Felix
Nestor, Peter
Peters, Oliver
Priller, Josef
Pross, Verena
Ramirez, Alfredo
Schneider, Anja
Speck, Oliver
Spruth, Eike Jakob
Teipel, Stefan
Vukovich, Ruth
Westerteicher, Christine
Wiltfang, Jens
Wolfsgruber, Steffen
Wagner, Michael
Düzel, Emrah
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen (BN012)
Article History
Received: 28 May 2017
Accepted: 4 October 2017
First Online: 7 February 2018
Ethics approval and consent to participate
: The study protocol was approved by the ethical committees of the medical faculties of all participating sites: the ethical committees of Berlin (Charité, University Medicine), Bonn, Cologne, Göttingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and Tübingen. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn. The registration number of the trial at the ethical committee in Bonn is 117/13.
: Not applicable.
: The authors declare that they have no competing interests with regard to the content of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.